Peel Hunt restated their buy rating on shares of Craneware plc (LON:CRW) in a research note published on Thursday morning. The firm currently has a GBX 1,335 ($17.43) target price on the stock.

Shares of Craneware plc (LON:CRW) opened at 1287.50 on Thursday. Craneware plc has a 52 week low of GBX 660.00 and a 52 week high of GBX 1,309.10. The firm’s market capitalization is GBX 345.69 million. The firm’s 50-day moving average is GBX 1,083.18 and its 200-day moving average is GBX 874.68.

The firm also recently announced a dividend, which will be paid on Thursday, December 8th. Stockholders of record on Thursday, November 10th will be paid a dividend of GBX 9 ($0.12) per share. This represents a dividend yield of 0.86%. This is a boost from Craneware plc’s previous dividend of $7.50. The ex-dividend date is Thursday, November 10th.

In other Craneware plc news, insider Neilson,Keith bought 5,388 shares of the stock in a transaction dated Monday, September 19th. The shares were bought at an average cost of GBX 1,200 ($15.66) per share, for a total transaction of £64,656 ($84,396.29).

About Craneware plc

Craneware plc is a United Kingdom-based company, which is engaged in the development, licensing and ongoing support of computer software for the United States healthcare industry. The Company operates in Edinburgh, Atlanta, Boston, Nashville and Phoenix. Its Revenue Integrity Solutions include five product families: Patient Access, Charge Capture & Pricing, Coding Integrity, Revenue Collection & Retention, and Data & Decision Enablement.

Receive News & Ratings for Craneware plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Craneware plc and related companies with's FREE daily email newsletter.